Palatin Techs Stock (AMEX: PTN) stock price, news, charts, stock research, profile.
Open | $2.120 |
Close | - |
Volume / Avg. | 164.404K / 640.206K |
Day Range | 2.080 - 2.210 |
52 Wk Range | 1.430 - 5.650 |
Market Cap | $35.178M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 0 |
Short Interest | 9.2% |
Days to Cover | 6.88 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Palatin Techs (AMEX: PTN) through any online brokerage.
Other companies in Palatin Techs’s space includes: NKGen Biotech (NASDAQ:NKGN), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP) and OncoCyte (NASDAQ:OCX).
The latest price target for Palatin Techs (AMEX: PTN) was reported by HC Wainwright & Co. on Thursday, May 2, 2024. The analyst firm set a price target for 17.00 expecting PTN to rise to within 12 months (a possible 679.82% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Palatin Techs (AMEX: PTN) is $2.18 last updated Today at May 6, 2024 at 10:45 AM EDT.
There are no upcoming dividends for Palatin Techs.
Palatin Techs’s Q3 earnings are confirmed for Friday, May 17, 2024.
There is no upcoming split for Palatin Techs.
Palatin Techs is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.